# : Pharmacokinetics of Enoxaparin After Coronary Artery Bypass Graft Surgery

> **NCT02474212** · PHASE4 · COMPLETED · sponsor: **Tampere University Hospital** · enrollment: 85 (actual)

## Conditions studied

- Venous Thromboembolism
- Pulmonary Embolism
- Thromboprophylaxis

## Interventions

- **DRUG:** Enoxaparin

## Key facts

- **NCT ID:** NCT02474212
- **Lead sponsor:** Tampere University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-05
- **Primary completion:** 2023-03-31
- **Final completion:** 2023-03-31
- **Target enrollment:** 85 (ACTUAL)
- **Last updated:** 2023-05-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02474212

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02474212, ": Pharmacokinetics of Enoxaparin After Coronary Artery Bypass Graft Surgery". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT02474212. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*